Radical prostatectomy versus external-beam radiotherapy for localized prostate cancer: Long-term effect on biochemical control-in search of the optimal treatment

Annals of Surgical Oncology

Volumn 18, Issue 10, 2011, Pages 2980-2987

  González San Segundo, Carmen ^a   Herranz Amo, Felipe ^a   Álvarez González, Ana ^a   Cuesta Álvaro, Pedro ^b   Gómez Espi, Marina ^a   Paños Fagundo, Eva ^a   Santos Miranda, Juan A ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERINEUM; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RADIATION SICKNESS;

ADULT; AGED; BRACHYTHERAPY; COHORT STUDIES; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME;

EID: 80052710730     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-1660-0     Document Type: Article

References (33)

1. PA Kupelian M Elshaikh CA Reddy C Zippe EA Klein 2002 Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy J Clin Oncol 20 3376 3385 12177097 10.1200/JCO.2002.01.150
2. FA Vicini A Martinez G Hanks, et al. 2002 An interinstitutional and interspecialty comparison of treatment outcome data for patients with prostate carcinoma based on predefined prognostic categories and minimum follow-up Cancer 95 2126 2135 12412166 10.1002/cncr.10919 (Pubitemid 35253374)
3. AV D'Amico R Whittington SB Malkowicz, et al. 2002 Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era Cancer 95 281 286 12124827 10.1002/cncr.10657 (Pubitemid 34787593)
4. I Thompson JB Thrasher G Aus, et al. 2007 Guidelines for the management of clinically localized prostate cancer: 2007 update J Urol 177 2106 2131 17509297 10.1016/j.juro.2007.03.003 (Pubitemid 46726449)
5. NCCN Clinical Practice Guidelines in Oncology. Prostate cancer. v.2.2009. Available at: http://www.nccn.org/.
6. Heidenreich A, Bolla M, Joniau S, et al. Guidelines on prostate cancer. 2009. Available at: http://www.uroweb.org/professional-resources/guidelines/.
7. AB Jani S Hellman 2003 Early prostate cancer: clinical decision-making Lancet 361 1045 1053 12660074 10.1016/S0140-6736(03)12833-4 (Pubitemid 36351377)
8. RE Peschel JW Colberg 2003 Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer Lancet Oncol 4 233 241 12681267 10.1016/S1470-2045(03)01035-0 (Pubitemid 36503321)
9. AV D'Amico R Whittington SB Malkowicz, et al. 1998 Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 969 974 9749478 10.1001/jama.280.11.969 (Pubitemid 28445094)
10. AJ Stephenson MW Kattan JA Eastham, et al. 2006 Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition J Clin Oncol 24 3973 3978 16921049 10.1200/JCO.2005.04. 0756 1:CAS:528:DC%2BD28Xps1Sit70%3D (Pubitemid 46630746)
11. M Roach III G Hanks H Thames Jr, et al. 2006 Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 965 974 16798415 10.1016/j.ijrobp. 2006.04.029
12. DF Paulson GH Lin W Hinshaw 1982 Radical surgery versus radiotherapy for adenocarcinoma of the prostate J Urol. 128 502 505 6811766 1:STN:280: DyaL3s%2FhtVCqsw%3D%3D
13. AD Vassil ES Murphy CA Reddy, et al. 2010 Five-year biochemical recurrence free survival for intermediate risk prostate cancer after radical prostatectomy, external beam radiation therapy or permanent seed implantation Urology 76 1251 1257 20378156 10.1016/j.urology.2010.01.010
14. CC Parker DP Dearnaley 2003 Radical radiotherapy for prostate cancer Cancer Treat Rev 29 161 169 12787711 10.1016/S0305-7372(03)00070-7 1:STN:280:DC%2BD3s3mtFalsQ%3D%3D (Pubitemid 36763941)
15. SH Stokes 2000 Comparison of biochemical disease-free survival of patients with localized carcinoma of the prostate undergoing radical prostatectomy, transperineal ultrasound-guided radioactive seed implantation, or definitive external beam irradiation Int J Radiat Oncol Biol Phys 47 129 136 10758314 10.1016/S0360-3016(99)00526-X 1:STN:280:DC%2BD3c3itlCisw%3D%3D (Pubitemid 30179686)
16. G Arcangeli L Strigari S Argandeli, et al. 2009 Retrospective comparison of external beam radiotherapy and radical prostatectomy in high-risk, clinically localized prostate cancer Int J Radiat Oncol Biol Phys 75 975 982 19395188 10.1016/j.ijrobp.2008.12.045
17. PA Blood T Pickles 2007 The median non-prostate cancer survival is more than 10 years for men up to age 80 years who are selected and receive curative radiation treatment for prostate cancer Radiat Oncol 2 17 21 17511871 10.1186/1748-717X-2-17
18. ML Blute EJ Bergstralh A Iocca B Scherer H Zincke 2001 Use of Gleason score, prostate specific antigen, seminal vesicle and margin status to predict biochemical failure after radical prostatec-tomy J Urol 165 119 125 11125379 10.1097/00005392-200101000-00030 1:STN:280:DC%2BD3M%2FovFWmtg%3D%3D
19. PA Kupelian L Potters D Khuntia, et al. 2004 Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy ≥72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer Int J Radiat Oncol Biol Phys 58 25 33 14697417 10.1016/S0360-3016(03)00784-3 (Pubitemid 38010333)
20. A Pollack GK Zagars G Starkschall, et al. 2002 Prostate cancer radiation dose response: results of the M.D. Anderson phase III randomized trial Int J Radiat Oncol Biol Phys 53 1097 1105 12128107 10.1016/S0360-3016(02)02829-8 (Pubitemid 34787842)
21. BA Jereczek-Fossa R Orecchia 2007 Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer Radiother Oncol 84 197 215 17532494 10.1016/j.radonc.2007.04.013 (Pubitemid 47299139)
22. AL Zietman K Bae JD Slater, et al. 2010 Adenocarcinoma of the prostate: long-term results from proton Radiation Oncology Group/American College of Radiology 95-09 J Clin Oncol 28 1106 1111 20124169 10.1200/JCO.2009.25.8475
23. MJ Zelefsky JA Eastham AM Cronin, et al. 2010 Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mix J Clin Oncol 28 1508 1513 20159826 10.1200/JCO.2009.22.2265
24. P Harnden MD Shelley H Clements, et al. 2007 The prognostic significance of perineural invasion in prostatic cancer biopsies. A systematic review Cancer 109 13 24 17123267 10.1002/cncr.22388 (Pubitemid 46120190)
25. HHM Yu DY Song YY Tsai T Thompson DA Frassica TL DeWeese 2007 Perineural invasion affects biochemical recurrence-free survival in patients with prostate cancer treated with definitive external beam radiotherapy Urology 70 111 116 17656219 10.1016/j.urology.2007.03.020 (Pubitemid 47081097)
26. F Ozcan 2001 Correlation of perineural invasion on radical prostatectomy specimens with other pathologic prognostic factors and PSA failure Eur Urol 40 308 312 11684847 10.1159/000049791 1:CAS:528:DC%2BD3MXotVGjtLk%3D (Pubitemid 34701901)
27. M Bolla H van Poppel L Collette, et al. 2005 Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 572 578 16099293 10.1016/S0140-6736(05)67101-2 (Pubitemid 41140332)
28. IM Thompson CM Tangen J Paradelo, et al. 2009 Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term follow up of a randomized clinical trial J Urol 181 956 962 19167731 10.1016/j.juro.2008.11.032
29. T Wiegel D Bottke U Steiner, et al. 2009 Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95 J Clin Oncol 27 2924 2930 19433689 10.1200/JCO.2008.18.9563
30. CS Chung MH Chen J Cullen D McLeod P Carroll A D'Amico 2008 Time to prostate-specific antigen nadir after androgen suppression therapy for postoperative or postradiation PSA failure and risk of prostate cancer-specific mortality Urology 71 136 140 18242382 10.1016/j.urology.2007.08.028 (Pubitemid 351181331)
31. ME Ray LB Levy EM Horwitz, et al. 2006 Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure Urology 68 1257 1262 17141830 10.1016/j.urology.2006.08.1056 (Pubitemid 44880342)
32. JB Malcolm MD Fabrizio BB Barone, et al. 2010 Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer J Urol 183 1822 1829 20303100 10.1016/j.juro.2009.12.102
33. MG Sanda RL Dunn J Michalski, et al. 2008 Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 1250 1261 18354103 10.1056/NEJMoa074311 1:CAS:528:DC%2BD1cXjvVWmtrc%3D (Pubitemid 351439226)